Baltimore, MD, United States of America

Ian Pitha-Rowe


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ian Pitha-Rowe: Innovator in Cancer Treatment

Introduction

Ian Pitha-Rowe is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. With a total of 2 patents, his work focuses on compositions and methods that aim to prevent and treat cancer.

Latest Patents

Ian's latest patents include groundbreaking compositions and methods for preventing and treating cancer by modulating UBE1L, ISG15, and/or UBP43. These patents describe the use of compositions that induce UBE1L or a ubiquitin-like protein ISG15, or inhibit a deconjugase UBP43 to degrade oncogenic proteins. The methods provided enhance apoptosis of cancerous or pre-cancerous cells, offering new avenues for cancer prevention and treatment.

Career Highlights

Ian Pitha-Rowe is affiliated with Dartmouth College, where he continues to advance his research in cancer therapies. His work is characterized by a commitment to developing effective treatments that can significantly impact patient outcomes.

Collaborations

Ian collaborates with esteemed colleagues such as Ethan Dmitrovsky and Sutisak Kitareewan, contributing to a dynamic research environment focused on innovative cancer solutions.

Conclusion

Ian Pitha-Rowe's contributions to cancer treatment through his patents and research at Dartmouth College highlight his role as a leading inventor in the field. His work promises to pave the way for new therapeutic strategies in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…